◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TRUP

Trupanion, Inc. - (TRUP) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NASDAQ · DATA UPDATED 2026-09-17

Trupanion, Inc. - (TRUP) operates in the NASDAQ industry and is headquartered in Seattle, United States with about 1,121 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, TRUP reported $1.4B in revenue and $19M in net income.

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Interactive charts & full statements → Open the TRUP valuation workbench →

TRUP Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31
Total Revenue	$1.5B	$1.4B	$1.3B	$1.1B	$905M	$699M	$502M	$384M	$304M	$243M	$188M	$147M	$116M	$84M	$56M	$37M
Gross Profit	$342M	$410M	$179M	$131M	$122M	$104M	$82M	$65M	$51M	$43M	$33M	$25M	$20M	$16M	$11M	$8M
Gross Margin %	22.5%	28.5%	13.9%	11.8%	13.5%	14.9%	16.3%	16.9%	16.9%	17.7%	17.7%	17.2%	17.2%	18.7%	20.2%	21.7%
Operating Income (EBIT)	$24M	$22M	($10M)	($41M)	($43M)	($35M)	($5M)	($2M)	($1M)	($3M)	($7M)	($17M)	($16M)	($7M)	($6M)	($3M)
Operating Margin %	1.6%	1.5%	-0.7%	-3.7%	-4.8%	-5.0%	-1.0%	-0.5%	-0.3%	-1.1%	-3.6%	-11.4%	-13.8%	-8.3%	-10.0%	-8.0%
Net Income	$24M	$19M	($10M)	($45M)	($45M)	($36M)	($6M)	($2M)	($1M)	($2M)	($7M)	($17M)	($21M)	($8M)	($6M)	($4M)
Net Margin %	1.6%	1.4%	-0.8%	-4.0%	-4.9%	-5.1%	-1.2%	-0.5%	-0.3%	-0.6%	-3.7%	-11.7%	-18.3%	-9.8%	-11.5%	-10.6%
EBITDA	$52M	$52M	$21M	($20M)	($29M)	($23M)	$3M	$5M	$5M	$3M	($3M)	($14M)	($13M)	($7M)	($5M)	($3M)
Earnings Per Share (EPS)	$0.53	$0.45	$-0.23	$-1.08	$-1.10	$-0.89	$-0.16	$-0.05	$-0.03	$-0.05	$-0.24	$-0.62	$-0.76	$-6.23	$-4.18	$-0.21
Shares Outstanding (M)	44M	44M	42M	41M	41M	40M	36M	35M	32M	30M	29M	28M	28M	1M	—	18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRUP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$393M	$384M	$377M	$367M	$354M	$342M	$337M	$327M
Gross Profit	$65M	$103M	$114M	$60M	$55M	$51M	$53M	$49M
Gross Margin %	16.6%	26.7%	30.3%	16.4%	15.5%	14.9%	15.7%	15.1%
Operating Income (EBIT)	$6M	$6M	$6M	$6M	$2M	($1M)	$0M	$2M
Operating Margin %	1.6%	1.6%	1.7%	1.6%	0.7%	-0.4%	0.1%	0.5%
Net Income	$7M	$5M	$6M	$6M	$9M	($1M)	$2M	$1M
Net Margin %	1.7%	1.3%	1.5%	1.6%	2.7%	-0.4%	0.5%	0.4%
EBITDA	$13M	$12M	$14M	$13M	$18M	$6M	$9M	$10M
Earnings Per Share (EPS)	$0.16	$0.11	$0.13	$0.13	$0.22	$-0.03	$0.04	$0.03
Shares Outstanding (M)	44M	44M	44M	44M	43M	43M	42M	43M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRUP Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31
Cash from Operations (CFO)	$94M	$89M	$48M	$19M	($8M)	$7M	$22M	$16M	$13M	$10M	$5M	($10M)	($11M)	($1M)	($2M)	$0M
Capital Expenditures (CapEx)	$12M	$14M	$10M	$18M	$17M	$12M	$7M	$5M	$60M	$3M	$2M	$5M	$6M	$1M	$2M	$1M
Free Cash Flow (FCF)	$82M	$75M	$39M	$0M	($25M)	($5M)	$14M	$11M	($47M)	$7M	$3M	($15M)	($16M)	($2M)	($4M)	($1M)
FCF Margin %	5.4%	5.2%	3.0%	0.0%	-2.8%	-0.7%	2.8%	2.8%	-15.5%	2.7%	1.6%	-10.4%	-14.2%	-3.0%	-6.5%	-2.0%
Dividends Paid	—	—	—	$15M	$7M	—	$12M	$16M	$17M	$0M	$0M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRUP Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$21M	$15M	$29M	$29M	$15M	$16M	$24M	$15M
Capital Expenditures (CapEx)	$2M	$1M	$4M	$5M	$3M	$2M	$2M	$2M
Free Cash Flow (FCF)	$19M	$14M	$25M	$24M	$12M	$14M	$22M	$13M
FCF Margin %	4.9%	3.6%	6.7%	6.5%	3.4%	4.1%	6.5%	4.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TRUP Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Assets	$931M	$915M	$807M	$783M	$672M	$563M	$498M	$257M	$208M	$106M	$82M	$71M	$98M	$52M	$28M
Cash & Cash Equivalents	$149M	$138M	$160M	$148M	$66M	$87M	$140M	$29M	$27M	$26M	$24M	$18M	$53M	$15M	$4M
Total Liabilities	$521M	$531M	$484M	$479M	$366M	$230M	$158M	$120M	$78M	$57M	$38M	$26M	$39M	$85M	$55M
Total Debt (Short + Long-Term)	$107M	$112M	$129M	$129M	$69M	$0M	$0M	$26M	$13M	$19M	$10M	$1M	$30M	$26M	$15M
Total Shareholders' Equity	$410M	$384M	$323M	$304M	$305M	$332M	$340M	$137M	$129M	$48M	$45M	$45M	$59M	($33M)	($27M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TRUP viewer.

Other Companies in Software & IT Services

LNN · Lindsay Corporation — $1 billion
BBNX · Beta Bionics, Inc. - — $1 billion
ECVT · Ecovyst Inc. — $1 billion
FCSS · Fidelity China Special Situations Ord — £1 billion
BPCR · BioPharma Credit Ord — $1 billion
CGI · Canadian General Investments Ord — C$1 billion
CPAC · Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares) — $1 billion
CRVS · Corvus Pharmaceuticals, Inc. - — $1 billion

← TRUO All “T” companies TRUR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.